SLAB earnings analysis
What we found in SLAB's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Silicon Laboratories delivered $228 million of revenue in the quarter, up approximately 6.5% sequentially and 18% year over year, while GAAP diluted EPS improved to $(0.32) from $(0.48) in the prior quarter and $(0.67) a year earlier. Adjusted profitability was stronger, with non-GAAP EPS of $0.71 and non-GAAP operating income of $26.825 million, but GAAP profitability, cash flow and current-period margin data were not available in the supplied filing extract. Sentiment remains neutral because forward guidance is suspended pending the proposed Texas Instruments merger, while merger execution, memory shortages, geographic concentration and distributor exposure remain significant risks.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue accelerated to $228M
- Revenue was $228 million, up $14 million, or approximately 6.5%, from $214 million in the prior quarter and up approximately 18% from $193 million in the prior-year quarter.
- GAAP EPS improved materially
- GAAP diluted EPS improved to $(0.32) from $(0.48) in the prior quarter and $(0.67) in the prior-year quarter, an improvement of $0.16 sequentially and $0.35 year over year.
- Adjusted profitability strengthened
- Non-GAAP EPS was $0.71 and non-GAAP operating income was $26.825 million, indicating materially better adjusted profitability than the GAAP result.
- Disclosure controls remain effective
- Management concluded that disclosure controls and procedures were effective as of July 4, 2026, and reported no change during the quarter that materially affected internal control over financial reporting.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Merger execution and termination risk
- The proposed merger remains subject to remaining closing conditions, including required regulatory approvals, despite stockholder approval on April 30, 2026. The merger agreement provides for a $259 million termination fee under specified circumstances, creating meaningful execution and downside risk if the transaction fails.
- Memory shortages and geopolitical exposure
- The filing identifies a current global shortage of memory components driven by AI-related demand, which could cause customers to reduce, delay or cancel orders. International exposure is significant: 90% of six-month revenue came from outside the United States, with China representing 19% by end-customer location and 31% by shipped-to location.
- Distributor and inventory concentration
- Distributor concentration and channel exposure remain material: distributors generated 75% of revenue during the six months ended July 4, 2026, while the two largest distributors accounted for 51%. The filing also states that the company builds products from customer forecasts before receiving binding purchase orders, increasing inventory and obsolescence risk.
- High R&D investment and execution risk
- Research and development expense was $183.6 million, or 41.6% of revenue, during the six months ended July 4, 2026. The filing highlights the risk that delays or failure of emerging technologies and standards to achieve market acceptance could reduce the value of these investments.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.32
What they said about what is next.
No quantitative revenue or EPS outlook was provided. Forward guidance remains suspended because of the pending merger with Texas Instruments.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 5, 2026
- Silicon Laboratories reported Q1 2026 results showing a revenue of $213.5 million, up 20.1% year-over-year, and improved gross margin of 59.5%. The company continues to incur losses as it prepares for a merger with…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing SLAB makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever